•  
  •  
  •  
  •  

2025-10-02 10:12:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  TexmacoInfrastructureandHoldings

Stock Report

  • Texmaco Infrastructure & Holdings Ltd recommends dividend of Rs. 0.15
  • Texmaco Infrastructure and Holdings Ltd Q4 FY2024-25 consolidated profit at Rs. 1.12 crore
  • Texmaco Infrastructure & Holdings Ltd consolidated Q1 FY2024-25 profit at Rs. 36.24 lakhs
  • Texmaco Infrastructure and Holdings Ltd Q4FY24 consolidated profit at Rs. 2.50 crore
  • Texmaco Infrastructure and Holdings Ltd Q2 FY2024 consolidated PAT up QoQ at Rs. 2.06 crore
  • Texmaco Infrastructure and Holdings Ltd consolidated Q1 FY2024 net profit at Rs. 33.27 lakhs
  • Texmaco Infrastructure & Holdings Limited recommends dividend of Rs. 0.15
  • Texmaco Infrastructure and Holdings Ltd Q4FY23 consolidated profit at Rs. 12.31 lakhs
  • Texmaco Infrastructure and Holdings Ltd Q3FY23 consolidated profit at Rs. 10.10 lakhs
  • Texmaco Infrastructure and Holdings Ltd Q2 FY2023 consolidated PAT up at Rs. 2.51 crore
  • Texmaco Infrastructure & Holdings Ltd recommends dividend of Rs. 0.075
  • Texmaco Infrastructure and Holdings Ltd Q4 FY2022 consolidated loss at Rs. 14.99 lakhs
  • Texmaco Infrastructure and Holdings Q3FY22 consolidated loss at Rs. 90.73 crores
  • Texmaco Infrastructure and Holdings Ltd posts consolidated PAT of Rs. 2.09 crore in Q2FY22

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024